Cargando…
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Autores principales: | Siklos, Marton I, Gandhi, Ronak P, Xiong, Rui, Schiefer, Isaac T, Litosh, Vladislav, VandeVrede, Lawren, Thatcher, Gregory RJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765657/ http://dx.doi.org/10.1186/2050-6511-14-S1-P65 |
Ejemplares similares
-
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
por: Thatcher, Gregory RJ, et al.
Publicado: (2013) -
Guanylate cyclase-C/cGMP: an emerging pathway in the regulation of visceral pain
por: Hannig, Gerhard, et al.
Publicado: (2014) -
Regulation of cGMP levels by guanylate cyclase in truncated frog rod outer segments
Publicado: (1989) -
PDGF regulates guanylate cyclase expression and cGMP signaling in vascular smooth muscle
por: Hildebrand, Staffan, et al.
Publicado: (2022) -
Effects of carbon monoxide-releasing molecules on cGMP levels and soluble guanylate cyclase activity
por: Marazioti, Antonia, et al.
Publicado: (2009)